This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richards, A. M. Articles by Yandle, T. Search for Related Content PubMed PubMed Citation Articles by Richards, A. M. Articles by Yandle, T.

Hypertension, Vol 13, 193-199, Copyright © 1989 by American Heart Association

ARTICLES

Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor

AM Richards, G Rao, EA Espiner and T Yandle
Department of Endocrinology, Princess Margaret Hospital, Christchurch, New Zealand.

The interaction of angiotensin converting enzyme (ACE) inhibition and atrial natriuretic factor (ANF) was investigated in six supine, sodium- replete, normal volunteers who received captopril (10 mg i.v. bolus followed by 10 mg/hr constant infusion) or vehicle superimposed on background 3-hour, constant, low-dose (1.5 pmol/kg/min) infusions of human ANF (99-126). Plasma converting enzyme activity was significantly inhibited but this had no effect on endogenous plasma ANF concentrations. ANF infusions, with or without captopril, caused similar increases in plasma ANF concentrations, and calculated metabolic clearance rates for ANF were unchanged. Similarly, blood pressure, heart rate, renal blood flow, glomerular filtration rate, and renal electrolyte excretion, including ANF-induced natriuresis, were unaffected by captopril. The combination of ANF plus captopril produced a significant increase in plasma aldosterone (79 +/- 8 vs. 60 +/- 6 pmol/l, p less than 0.05), cortisol (406 +/- 52 vs. 265 +/- 29 nmol/l, p less than 0.01), adrenaline (119 +/- 21 vs. 76 +/- 10 pg/ml, p less than 0.05), and noradrenaline (319 +/- 49 vs. 215 +/- 38 pg/ml, p less than 0.05) compared with time-matched placebo data. Converting enzyme inhibition, in the absence of major changes in blood pressure or renal blood flow, has little effect on ANF metabolism or renal bioactivity. However, ACE inhibition and ANF combined may interact to increase activity of the hypothalamo-pituitary-adrenal axis and sympathetic nervous system by unknown mechanisms.

This article has been cited by other articles:

				K. Doyama, M. Fukumoto, G. Takemura, M. Tanaka, T. Oda, K. Hasegawa, T. Inada, S. Ohtani, T. Fujiwara, H. Itoh, et al. Expression and distribution of brain natriuretic peptide in human right atria J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1832 - 1838. [Abstract] [Full Text] [PDF]

				A. J.H.M Houben, M. M.E Krekels, N. C Schaper, M. J.M.J Fuss-Lejeune, S. A Rodriguez, and P. W de Leeuw Microvascular effects of atrial natriuretic peptide (ANP) in man: studies during high and low salt diet Cardiovasc Res, August 1, 1998; 39(2): 442 - 450. [Abstract] [Full Text] [PDF]